Chronic progressive external ophthalmoplegia: MR spectroscopy and MR diffusion studies in the brain

American Journal of Roentgenology

Volumn 187, Issue 3, 2006, Pages 820-824

  Heidenreich, Jens O ^a,b   Klopstock, Thomas ^c   Schirmer, Timo ^b   Saemann, Philipp ^b   Mueller Felber, Wolfgang ^c   Auer, Dorothee P ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Brain; CNS; Diffusion weighted MRI; MRI; Ophthalmoplegia

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; MITOCHONDRIAL DNA; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN LEVEL; CEREBELLUM ATROPHY; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; KEARNS SAYRE SYNDROME; MALE; MITOCHONDRIAL MYOPATHY; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; BRAIN; BRAIN DISEASE; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADULT; AGED; BRAIN; BRAIN DISEASES; CASE-CONTROL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL;

EID: 33748455870     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0180     Document Type: Article

References (27)

1. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995; 333:638-644
2. Barkovich AJ, Good WV, Koch TK, et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Am J Neuroradiol 1993; 14:1119-1137
3. Fadic R, Johns DR. Clinical spectrum of mitochondrial disease. Semin Neurol 1996; 16:11-20
4. Kearns T, Sayre G. Retinitis pigmentosa, external ophthalmoplegia, and complete heart block. Arch Ophthalmol 1958; 60:280-289
5. Daroff RB, Solitare GB, Pincus JH, et al. Spongiform encephalopathy with chronic progressive external ophthalmoplegia: central ophthalmoplegia mimicking ocular myopathy. Neurology 1966; 16:161-169
6. Oldorfs A, Fyhr I-M, Holme E, et al. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol (Berl) 1990; 80:541-546
7. Provenzale JM, VanLandingham K. Cerebral infarction associated with Kearns-Sayre syndrome-related cardiomyopathy. Neurology 1996; 46:826-828
8. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. Am J Neuroradiol 1995; 16:233-239
9. Purucker M, Schröder R, Harms L, et al. Reversible focal brain edema in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) syndrome. J Epilepsy 1996; 9:79-82
10. Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996; 46:223-227
11. 31P-MR spectroscopy in patients with MELAS. J Neurol Sci 1998; 155:182-185
12. Pavlakis SG, Kingsley PB, Kaplan GP, et al. Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 1998; 55:849-852
13. Berkovic S, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF): a clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomography study. Brain 1989; 112:1231-1260
14. Matthews PM, Berkovic SF, Shoubridge EA, et al. In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalopathy (MERRF). Ann Neurol 1991; 29:435-438
15. Leutner C, Layer G, Zierz S, et al. Cerebral MR in ophthalmoplegia plus. Am J Neuroradiol 1994; 15:681-687
16. Wray SH, Provenzale JM, Johns DR, et al. MR of the brain in mitochondrial myopathy. Am J Neuroradiol 1995; 16:1167-1173
17. Carlow TJ, Depper MH, Orison WW. MR of extraocular muscles in chronic progressive external ophthalmoplegia. Am J Neuroradiol 1998; 19:95-99
18. De Stefano N, Matthews PM, Ford B, et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45:1193-1198
19. 1H-MRS study. Neurology 1994; 44:557-559
20. Kapeller P, Fazekas F, Offenbacher H, et al. Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome. J Neurol Sci 1996; 135:126-130
21. Salvan AM, Vion-Dury J, Confort-Gouny S, et al. Brain metabolic profiles obtained by proton MRS in two forms of mitochondriopathies: Leber's hereditary optic neuropathy and chronic progressive external ophthalmoplegia. Eur Neurol 1998; 40:46-49
22. Dichgans M, Pütz B, Boos D, et al. Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion. Am J Neuroradiol 2003; 24:1083-1089
23. Engelbrecht V, Scherer A, Rassek M. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002; 222:410-418
24. Conturo TE, McKinstry RC, Akbudak E, et al. Encoding of anisotropic diffusion with tetrahedral gradients: a general mathematical diffusion formalism and experimental results. Magn Reson Med 1996; 35:399-412
25. 1H-MRSI study. Neurology 2001; 56:635-642
26. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679
27. Pellock JM, Behrens M, Lewis L, et al. Kearns-Sayre syndrome and hypoparathyroidism. Ann Neurol 1978; 3:455-458